Life ScienceCompany
Catalent M&A Summary
Catalent has acquired 17 companies of its own, including 10 in the last 5 years. A total of 4 acquisitions came from private equity firms. It has also divested 2 assets.
Catalent’s largest acquisition to date was in 2019, when it acquired Paragon Bioservices for $1.2B. Catalent has acquired in 7 different US states, and 6 countries. The Company’s most targeted sectors include life science (63%) and medical products (19%).
Catalent Ownership
Who owns Catalent?
Catalent is owned by Novo Holdings A/S. It was acquired on February 5, 2024.
Is Catalent PE-backed?
Yes. Catalent is owned by private equity investor Novo Holdings A/S.
Was Catalent formerly PE-backed?
Yes. Catalent was formerly owned by 3 private investors.
Catalent Business Overview
Where is Catalent headquartered?
Catalent is headquartered in Somerset, New Jersey.
What is Catalent’s revenue?
Catalent disclosed revenue of 4,263M USD for 2023 and 4,828M USD for 2022.
What sector is Catalent in?
Catalent is a life science company.
When was Catalent founded?
Catalent was founded in 2007.
M&A Summary
-
M&A Total Activity18
- M&A Buy Activity16
- M&A Sell Activity2
- Total Sectors Invested 5
- Total Countries Invested 6
- M&A Buy/Sell Connections 12
- M&A Advisors 4
Unlimited Searches
